US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

92.91

-0.1200-0.13%

Volume:11.40K

Turnover:1.06M

Market Cap:403.23M

PE:51.81

High:93.97

Open:93.28

Low:92.77

Close:93.03

52wk High:98.82

52wk Low:67.69

Shares:4.34M

Float Shares:4.34M

Volume Ratio:1.07

T/O Rate:0.26%

Dividend:1.55

Dividend Rate:1.67%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.63

PE(LYR):4.98

Loading ...

Overview Company News Filings

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)

THOMSON REUTERS

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Biogen, Eisai announce positive recommendation for Leqembi in Canada

Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease

THOMSON REUTERS

Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says

MT Newswires Live

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31

Political and General News Events from August 31

Zenas BioPharma Highlights FDA Review Acceptance for Obexelimab IgG4-RD Filing in Corporate Presentation

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Alnylam announces new data at ESC Congress on AMVUTTRA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/PBE/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":92.91,"timestamp":1789156800000,"preClose":93.03,"halted":0,"volume":11398,"delay":0,"changeRate":-0.0012899064817801199,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"Pre-Mkt","change":-0.12,"latestTime":"09-14 04:01:23 EDT","open":93.28,"high":93.97,"low":92.77,"amount":1062234.170828,"amplitude":0.012899,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":92.91,"sharesOutstanding":3180000,"nav":93.09028,"aum":404801564.79,"dividendRate":0.0167,"bidAskSpread":0.002045,"postHourTrading":{"tag":"盘后","latestPrice":92.91,"preClose":92.91,"latestTime":"19:30 EDT","volume":228,"amount":21182.6408,"timestamp":1789169404932,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0673683676295047,"impliedVol":0.0627,"impliedVolPercentile":0.012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":1.0673683676295047,"shares":4340000,"dividePrice":1.5516,"high":93.97,"amplitude":0.012899,"preClose":93.03,"low":92.77,"week52Low":67.69,"pbRate":"1.63","psRate":"234.89","week52High":98.82,"institutionHeld":0.2552,"latestPrice":92.91,"eps":1.793292,"divideRate":0.0167,"volume":11398,"delay":0,"ttmEps":1.793292,"open":93.28,"prevYearClose":82.15,"prevWeekClose":97.6367,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":98.7191,"twentyDayClose":94.2238,"sixtyDayClose":84.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664855195","title":"Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855195?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA7B47WD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","STOK","BMED","BIIB","BK4532","IE00B19Z9P08.USD","PBE","BK4585","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU0109394709.USD","LU0234570918.USD","BK4139","BK4533","LU0320765992.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385377","title":"UK Regulator Suspends Avacopan Vifor for New Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385377","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385377?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:03","pubTimestamp":1788260615,"startTime":"0","endTime":"0","summary":"The UK's health regulator has suspended the use, supply and sale of Avacopan Vifor, previously known as Tavneos, for new patients from Sept. 1, the watchdog said Tuesday.The Medicines and Healthcare products Regulatory Agency said available evidence no longer supports a positive benefit-risk balance for the medicine, which is used to treat some rare autoimmune diseases affecting small blood vessels.Tavneos was originally developed by ChemoCentryx, which was acquired by Amgen  in 2022, according to Amgen's website.The regulator said it reached its decision after reviewing all available evidence, advice from the Commission on Human Medicines, and feedback from patients and healthcare professionals.The supply will be allowed to existing patients during a six-month managed withdrawal period to allow safe alternative treatment options, the regulator said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","BK4534","IE0002141913.USD","BK4566","LU0122379950.USD","LU2468319806.SGD","BBH","LU2112291526.USD","BK4533","IE00B4R5TH58.HKD","AMGN","LU1571399168.USD","BK4581","BK4599","IE00BJT1NW94.SGD","BK4585","LU0058720904.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2242646821.SGD","LU0868494617.USD","IBB","PBE","LU0889565916.HKD","BIB","LU1057294990.SGD","BK4588","LU1061106388.HKD","BK4139","LU1983299246.USD","IBBQ","PJP","LU2242652126.USD","LU0109394709.USD","LU1023059063.AUD","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0289739699.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287830","title":"Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:40","pubTimestamp":1788255621,"startTime":"0","endTime":"0","summary":"Goldman Sachs analysts added Vertex Pharmaceuticals (VRTX) to the firm’s US Conviction List as part of its monthly update. Goldman believes Vertex ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","BBH","GSX","SGXZ57979304.SGD","LU2237443382.USD","LU1815336091.USD","LU2237443895.HKD","IE0002270589.USD","BK4127","LU2362541513.USD","VERX","LU2471134952.CNY","LU0757428866.USD","LU1668664300.SGD","IE00BZ9MQY76.HKD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IDNA","LU0432979614.USD","LU2236285917.USD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU2471134796.USD","TBXU","LU0345770993.USD","IE0002141913.USD","LU1035775433.USD","LU2362540622.SGD","LU1894683264.USD","VRTX","BK4504","PBE","IBB","LU1430594728.SGD","IE00BSNM7G36.USD","LU1093756325.SGD","GNMX","LU0868494708.USD","IBBQ","LU1585245621.USD","IE0034235188.USD","LU2362541273.HKD","LU1868836914.USD","LU2471134879.HKD","IE00B2B36J28.USD","LU0417517546.SGD","LU0106831901.USD","LU1778281490.HKD","IE0004091025.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837149","title":"UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837149?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:29","pubTimestamp":1788254980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S0UF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","TBXU","LU1061106388.HKD","PBE","IE00B4R5TH58.HKD","IBB","IE00B2B36J28.USD","LU1023059063.AUD","AMGN","LU2242646821.SGD","SG9999001440.SGD","BK4581","LU0058720904.USD","PJP","LU1057294990.SGD","LU1571399168.USD","BK4585","BK4566","LU2089984988.USD","BK4534","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4139","IE00BJJMRZ35.SGD","BK4599","LU0868494617.USD","LU1983299246.USD","LU0122379950.USD","LU2112291526.USD","BBH","BK4533","IE0009355771.USD","BK4588","BIB","IBBQ","LU0289739699.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832384","title":"Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832384","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:18","pubTimestamp":1788250703,"startTime":"0","endTime":"0","summary":"Amgen (NasdaqGS:AMGN) reported new Phase 3 VESALIUS-CV trial results for Repatha (evolocumab) showing a reduction in risk of death for high-risk adults without prior heart attack or stroke, presented at the European Society of Cardiology Congress 2026.\nThe findings extend evidence for Repatha to a broader high-risk population beyond patients with established cardiovascular events.\nAmgen highlighted that the data may inform future treatment guidelines and prescribing decisions in...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0289739699.SGD","IBBQ","IE0009355771.USD","BK4599","IE00B2B36J28.USD","PJP","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","BK4533","BBH","LU1023059063.AUD","LU2112291526.USD","BK4534","LU2468319806.SGD","BK4139","LU2242646821.SGD","LU1983299246.USD","AMGN","LU2089984988.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1571399168.USD","BK4581","PBE","TBXU","BK4566","BIB","BK4585","LU2242652126.USD","LU0868494617.USD","LU0058720904.USD","IE0002141913.USD","SG9999001440.SGD","LU1061106388.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRKW","LU1778281490.HKD","BRKC","IE0002141913.USD","LU2462157665.USD","BIB","IE00BZ9MQY76.HKD","LU0058720904.USD","LU1815336091.USD","LU2362541513.USD","LU1069344957.HKD","BK4139","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BRKL","IBB","VERX","LU0109394709.USD","ACTV","LU1585245621.USD","LU0757428866.USD","TBXU","PBE","LU2468319806.SGD","LU1559883803.SGD","LU2456880835.USD","ACKY","LU0320765992.SGD","SG9999001176.USD","BRKD","LU0889565916.HKD","LU1674673428.USD","IE00B2B36J28.USD","BRKU","BBH","IE00BFTCPJ56.SGD","LU0061475181.USD","IBBQ","BK4588","LU0417517546.SGD","LU2237438978.USD","LU0256863811.USD","VRTX","IDNA","LU0234570918.USD","LU1035775433.USD","BK4567","GNMX","IE00B19Z9P08.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z3B42.SGD","LU1674673428.USD","LU2362540622.SGD","LU0289739699.SGD","LU1430594728.SGD","IBB","LU1778281490.HKD","IDNA","BIB","LU1674673691.USD","LU1035775433.USD","LU0889565916.HKD","TACU","BK4532","LU0823416689.USD","SG9999001176.USD","LU1815336091.USD","LU2089984988.USD","LU0234570918.USD","LU0432979614.USD","VRTX","IE0009355771.USD","LU1069344957.HKD","BK4139","IE0002141913.USD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","SG9999001176.SGD","IE00B19Z9Z06.USD","LU1559883803.SGD","BBH","TSPA","BK4588","PBE","BK4585","LU0079474960.USD","GNMX","LU1093756168.USD","IBBQ","LU0061475181.USD","LU0566484027.USD","LU2417539215.USD","SGXZ57979304.SGD","LU0109394709.USD","VERX","IE00BZ9MQY76.HKD","CDIG","TBXU","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4550","LU2468319806.SGD","SG9999002224.SGD","IE00BLSP4239.USD","IBB","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0225284248.USD","LU1057294990.SGD","BK4534","IE00BLSP4452.SGD","IBBQ","IE00B3T34201.USD","300485","BK4566","LU1883839398.USD","BIB","OZEM","SG9999001176.SGD","LU0889565916.HKD","CSL.AU","LU0320765992.SGD","PBE","AMGN","LU2112291526.USD","BK7511","SGXZ57979304.SGD","TBXU","IE0002141913.USD","BBH","BK4505","LU0306806265.USD","IE00BJT1NW94.SGD","LU0321505439.SGD","LU1894683348.USD","688235","LU0868494617.USD","LU1983299246.USD","BBIO","LU2242646821.SGD","BK0046","PJP","PFE","IONS","IE00BBT3K403.USD","BK0028","IE0002270589.USD","IE00BJJMRZ35.SGD","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000087","title":"Biogen, Eisai announce positive recommendation for Leqembi in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000087","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000087?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:10","pubTimestamp":1788199810,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen Canada (BIIB) announced receipt of the Canada’s Drug Agency’ final positive recommendation supporting public reimbursement...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-eisai-announce-positive-recommendation-for-leqembi-in-canada-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-eisai-announce-positive-recommendation-for-leqembi-in-canada-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9Z06.USD","BK4588","IE00B894F039.SGD","BMED","BK4585","BIIB","BK4139","LU0109394709.USD","IE00B19Z9P08.USD","LU0320765992.SGD","PBE","BK4007","BK4532","ESAIY","LU0234570918.USD","LU0889565916.HKD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664300705","title":"Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664300705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664300705?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:07","pubTimestamp":1788199651,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z9P08.USD","BK4585","LU0234570918.USD","BK4532","BMED","IE00B19Z9Z06.USD","BK4139","LU0320765992.SGD","BK4533","BIIB","LU0109394709.USD","LU0889565916.HKD","PBE","BK4588","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002891","title":"Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002891?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:40","pubTimestamp":1788190844,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals' (ALNY) latest data strengthen the case for Nucresiran and TRITON-CM success, while supporting near-term upside for the stock, Oppenheimer said in a note Sunday.The analysts sa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","ALNY","BK4585","LU0889565916.HKD","LU0114720955.EUR","GNMX","BK4139","BK4548","LU0882574055.USD","LU0320765992.SGD","BK4588","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663321004","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663321004","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663321004?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:01","pubTimestamp":1788188477,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-08-31Nasdaq 100.NDXTop PerformersPercent ChangeTesla IncTSLA.OQ+4.6%CrowdStrike Holdings, Inc.CRWD.OQ+3.8%QUALCOMM Incorp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL8N44S1CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360107168.USD","LU1852331112.SGD","AXUP","LU2357305700.SGD","SNDQ","TSLT","QQQ","BK4023","SCHA","BK4598","LU2063271972.USD","PBE","LU0133085943.USD","QQQG","LU2286300806.USD","LU1066051811.HKD","LU0053666078.USD","BK4555","IE00BWXC8680.SGD","TSLI","LU0466842654.USD","LU1674673428.USD","BK4612","LU0097036916.USD","LU1935042991.SGD","PSQ","BK4579","QCOM","IE00BSNM7G36.USD","LU0345769631.USD","LU0234572021.USD","TQQQ","GUNZ","LU0079474960.USD","LIT","TSLP","ESPO","LU1169589451.USD","STSLAmain","XLC","LU1280957306.USD","BK4566","LU1923623000.USD","LU2462157665.USD","IE00B19Z8X17.USD","LU1429558221.USD","BK4515","BK4533","HERO","QCML","IGV","CRWL","WATS","LU1674673691.USD","BK4573","LU2023250330.USD","LU2456880835.USD","BK4551","BK4604","TSLO","BNGE","IE0009356076.USD","BK4097","07766","LU1914381329.SGD","QLD","SG9999015952.SGD","HK0000914686.HKD","NERD","TSDD","LU2360106780.USD","LU0345770308.USD","LU1244550221.USD","LU0198837287.USD","LU1119994496.HKD","BK4548","BK4554","BK4139","LU1917777945.USD","LU2108987350.USD","LU2265009873.SGD","GB00BDT5M118.USD","09834","BK4613","LU1244550577.SGD","SG9999000418.SGD","03086","TSLY","LU1548497426.USD","IE0004445239.USD","IE0034235303.USD","IE00B1XK9C88.USD","LU2213496289.HKD","LU1084165304.USD","LU1778281490.HKD","LU2750360997.AUD","SG9999002232.USD","LU2168564065.EUR","IE00B19Z9Z06.USD","LU2326559502.SGD","IE00BGHQDM52.EUR","CIBR","BK4141","LU0109394709.USD","LU1496350502.SGD","FSMD","IE00B19Z9505.USD","SPAM","LU0390134368.USD","LU2756315664.SGD","BK4512","09366","TSLZ","CLOD","LU1935043536.SGD","BK4085","LTL","NDX","LU0882574055.USD","LU0943347566.SGD","LU1551013342.USD","LU2471134952.CNY","QDEC","LU0964807845.USD","BK4528","BK4534","LU1069344957.HKD","LU2250418816.HKD","LU2087621335.USD","LU1712237335.SGD","LU2602419157.SGD","LU1623119135.USD","LU1951198990.SGD","IE00B894F039.SGD","LU2290526834.HKD","LU1992135399.USD","LU2168564495.EUR","HAKY","LU1629891620.HKD","BK4527","IE00B19Z9P08.USD","LU0823421416.USD","LU0963586101.USD","LU1323610961.USD","LU0109391861.USD","BK4588","LU0320765059.SGD","TESL","BK4099","09086","QID","TLA","SNDG","LU1066051498.USD","09766","NJAN","SQQQ","QQQM","NJUL","XAR","LU2211815571.USD","SMOG","LU0889565916.HKD","LU2125909759.SGD","LU1235294995.USD","LU1989773731.SGD","CNAV","SG9999015945.SGD","LU0114720955.EUR","LU0316494557.USD","LU1551013425.SGD","IE00B19Z8W00.USD","03034","LU2543165471.USD","BK4170","BK4585","IE00BK4W5L77.USD","LU1923622614.USD","IE00B5949003.HKD","IE00BZ9MQY76.HKD","TDV","PSWD","TESC","LU1232071149.USD","NAPR","LU1951200564.SGD","LU1804176565.USD","SG9999015986.USD","LU2023250504.SGD","LU0719512351.SGD","LU2249611893.SGD","QCMU","LU0054578231.USD",".HXC","HK0000914660.USD","LU1366192091.USD","ELOL","LU0081259029.USD","LU0107464264.USD","LU1861559042.SGD","SG9999001424.SGD","WANT","LU2272731600.USD","ALNY","LU0348723411.USD","LU0077335932.USD","LU1035775433.USD","BK4516","BK4511","LU2750360641.GBP","SCHM","LU2168564149.EUR","07366","LU1066051225.USD","TEST","LU1861220033.SGD","BK4524","TSII","LU0323591593.USD","LU0820561909.HKD","FCUS","LU2471134523.USD","LU0234570918.USD","SNDK","IE00BVYPNQ40.USD","IDRV","LU0345770993.USD","LU0868494617.USD","LU2168564222.USD","LU0345769128.USD","LU1145028129.USD","SQCOMmain","LU1992135472.HKD","BK4574","LU1066053197.SGD","LU0689472784.USD","LU0823414478.USD",".IXIC","LU2236285917.USD","RSPC","LU0820562030.AUD","LU1974910355.USD","LU0823421333.USD","SHPD","SG9999002224.SGD","LU1720051108.HKD","LU2420271590.USD","LU2125909593.SGD","LU1435385759.SGD","QQQX","LU2272731782.SGD","QMAR","LU1720051017.SGD","SNXX","AXON","LU1861215975.USD","BK4581","TSLW","LU0210536198.USD","BK4116","BK4561","LU0056508442.USD","WDAY","TTWO","FTXL","CRWD","TSLG","TSYY","LU2264538146.SGD","TQQY","CRWC","IE00BVYPNP33.GBP","LU0868494708.USD","COWG","LU0672654240.SGD","TSL","LU2125909916.SGD","LU0942090050.USD","SNDU","TMSL","BK4560","OPTZ","LU0708995401.HKD","LU0314104364.USD","GNMX","LU1064131342.USD","IE00BK4W5M84.HKD","BK4550","LU2471134879.HKD","CRSH","03455","BK4605","LU0266013472.USD","IE00B1BXHZ80.USD","LU1267930730.SGD","LU2517655028.SGD","07266","SHOP","SNDC","LU2403377893.USD","LU0320765992.SGD","SHPU","LU2517655374.HKD","IE00BJLML261.HKD","LU2106854487.HKD","LU0061475181.USD","BK4592","AIPI","LU2896262040.SGD","TSLQ","LU1244550494.USD","TSLA","LU2125909247.SGD","LU2168563687.JPY","LU2471134796.USD","BK4187","LU2517655291.USD","LU2756315318.SGD","BK4543","LU0820561818.USD","LU2433249047.HKD","LU1988902786.USD","SG9999015978.USD","07261","BUG","TSLR","BK4575","BK4532","FDRV","LU0082616367.USD","LU1923622291.USD","LU2247934214.USD","LU1046421795.USD","LU1169590202.USD","LU1823568750.SGD","LU1989763005.USD","QCMD","LU1691799644.USD","WCBR","NOCT","02834","DISK","GPIQ","07568","LU0640476718.USD","TSLS","LU0823411888.USD","EYES","TSLL","LU1861558580.USD","LU1261432733.SGD","LU2417539215.USD","07522","LU1839511570.USD","PTF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","IE0002141913.USD","BIB","BK4534","LU0058720904.USD","LU1057294990.SGD","AMGN","BK4139","LU2242652126.USD","IE00BJT1NW94.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","IBB","LU0289739699.SGD","LU0109394709.USD","LU1061106388.HKD","TBXU","PBE","LU1023059063.AUD","LU1983299246.USD","LU2468319806.SGD","BK4566","BK4581","LU0320765992.SGD","LU0889565916.HKD","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","BBH","IE00BFTCPJ56.SGD","BK4599","IBBQ","BK4588","LU2112291526.USD","PJP","SG9999001440.SGD","LU0868494617.USD","BK4533","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663400588","title":"Zenas BioPharma Highlights FDA Review Acceptance for Obexelimab IgG4-RD Filing in Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2663400588","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663400588?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:51","pubTimestamp":1788180706,"startTime":"0","endTime":"0","summary":"Zenas BioPharma highlights FDA review acceptance for obexelimab IgG4-RD filing in corporate presentationZenas Biopharma outlined plans to seek US approval for obexelimab in IgG4-related disease, with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLbbwccJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","ZBIO","PBE","BK4139","RPRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008638","title":"Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008638?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:50","pubTimestamp":1788177029,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNT...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-lakefront-biotherapeutics-lkft-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-lakefront-biotherapeutics-lkft-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTX","BK4585","LU0889565916.HKD","LABU","LU0114720955.EUR","BK4568","BK4588","LKFT","BK4581","BK4535","BK4137","XBI","BK4551","LU0882574055.USD","LU0109394709.USD","PBE","ALNY","LU0029874061.USD","LU0128526141.USD","LU0320765992.SGD","GNMX","HCSG","BK4139","XLV","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2242652126.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0289739699.SGD","LU2468319806.SGD","LU0868494617.USD","BK4534","LU2089984988.USD","IE0002141913.USD","IE0009355771.USD","LU2112291526.USD","PJP","IE00BFTCPJ56.SGD","BK4599","LU1061106388.HKD","IE00BJT1NW94.SGD","BBH","LU0320765992.SGD","TBXU","SG9999001440.SGD","LU2242646821.SGD","BK4581","LU1983299246.USD","BK4585","IBB","BK4139","IBBQ","BK4533","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1057294990.SGD","LU0058720904.USD","IE00B4R5TH58.HKD","BK4566","LU0122379950.USD","PBE","BIB","AMGN","LU1571399168.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079169","title":"Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079169?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:30","pubTimestamp":1788168608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Alnylam Pharma (ALNY) wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-boston-scientific-bsx-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-boston-scientific-bsx-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU2362540622.SGD","XLV","LU1989764748.USD","BK4504","LU0345769631.USD","IE0002141913.USD","LU1720051108.HKD","LU0889565916.HKD","LU0077335932.USD","BK4585","BK4548","BSX","LU2362541513.USD","LU2242649171.HKD","GNMX","PBE","LU1720051017.SGD","IE0009355771.USD","LU0128526141.USD","XBI","LU2244417387.USD","LU0225283273.USD","IE00BJJMRZ35.SGD","LABU","LU0251132253.USD","LU1718418525.SGD","ALNY","LU0048584097.USD","LU0267386448.USD","IE00B4R5TH58.HKD","LU2506951958.HKD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU1804176565.USD","BK4139","LU1791710400.SGD","LU0114720955.EUR","LU2506952170.USD","LU0353189763.USD","LU0320765992.SGD","LU1989764664.SGD","LU0138981039.USD","LU1989772840.SGD","LU2491050071.SGD","LU1153585028.USD","LU0266013472.USD","LU0109394709.USD","HCSG","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU1983299246.USD","AMGN","BK4581","LU2468319806.SGD","LU2242646821.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE0002141913.USD","LU1057294990.SGD","LU2089984988.USD","LU2112291526.USD","BIB","BK4588","LU2242652126.USD","LU1061106388.HKD","BK4566","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0058720904.USD","LU1571399168.USD","IBB","PBE","PJP","IBBQ","BBH","TBXU","IE00BJT1NW94.SGD","BK4139","LU0868494617.USD","LU1023059063.AUD","SG9999001440.SGD","BK4534","BK4599","LU0109394709.USD","LU0122379950.USD","BK4533","IE0009355771.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","BIB","PJP","TBXU","LU1023059063.AUD","BK4585","LU0889565916.HKD","BK4581","LU2089984988.USD","IE00B4R5TH58.HKD","IBB","IBBQ","LU0320765992.SGD","LU0289739699.SGD","LU2468319806.SGD","PBE","LU2242652126.USD","BK4588","BK4139","IE00BFTCPJ56.SGD","AMGN","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","LU2112291526.USD","BBH","LU1571399168.USD","LU0868494617.USD","LU1057294990.SGD","LU0058720904.USD","BK4534","IE00B2B36J28.USD","IE0002141913.USD","BK4566","SG9999001440.SGD","LU0122379950.USD","LU2242646821.SGD","BK4599","LU0109394709.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047585","title":"Alnylam announces new data at ESC Congress on AMVUTTRA","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047585","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663047585?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:20","pubTimestamp":1788121206,"startTime":"0","endTime":"0","summary":"Alnylam (ALNY) Pharmaceuticals announced new data at the European Society of Cardiology, ESC, Congress 2026 demonstrating the strength of RNAi-powe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-announces-new-data-at-esc-congress-on-amvuttra-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-announces-new-data-at-esc-congress-on-amvuttra-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","BK4588","LU0882574055.USD","BK4139","LU0320765992.SGD","EPV","GNMX","BK4548","BK4585","ALNY","LU0114720955.EUR","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}